offers the ability for patients with the condition to manage their own care using digital tools , in a supported self-management model of care .
We were included as a partner in the funding application , providing support on project governance , continuing adoption strategy , and the dissemination of the project ’ s results . We also provided advice on further adoption and spread as part of the project ’ s steering group .
York Health Economics Consortium ( YHEC ) was commissioned to supply an independent health economic evaluation of Lenus Health ’ s technology . The evaluation showed the following benefits for this technology :
• 50 % reduction in A & E attendance by COPD patients .
• 50 % reduction in hospital admissions for patients with COPD .
• Improved quality of life reported by patients .
• Over £ 1,500 cheaper and more effective , per patient per annum , than the current standard of care .
The study at the trust has been led by a respiratory consultant , with input from respiratory nurses who manage COPD clinics . It recruited patients from the hospital following an admission or virtual ward stay , who were then provided with a digital app to self-report and recognise their symptoms , access selfmanagement resources and directly communicate with the clinical team if there was cause for concern . This helped patients to identify and flag when they were at an early risk of exacerbation so that appropriate interventions could be actioned by the clinical team , informed by the data captured from the patient and shared in the services ’ clinical dashboard .
The trust was encouraged to implement Lenus Health ’ s technology due to strong evidence of success from previous implementations in Glasgow . The new evaluation in Hull
generated similar results , strengthening the case for the continued use of the technology and for further spread and adoption elsewhere .
Together with Humber and North Yorkshire Integrated Care Board ( ICB ), we are supporting Lenus Health with the further evaluation of this technology . The ICB will also be supporting the dissemination of results of the evaluation undertaken with YHEC to respiratory stakeholders across the region and nationally . Reducing COPD readmissions in Hull
19 Transforming Lives Through Innovation